News und Analysen
Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Tuesday, December 14
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present at the Virtual Non-Deal Roadshow series
Eutelsat Wins "strategic Transaction of the Year” Award for Its Investment in OneWeb
Regulatory News:
Eutelsat communications (Euronext Paris: ETL) is delighted to receive the "Strategic Transaction of the Year” award at this year's World Satellite Business Week in recognition of
DGAP-News: GEA Group Aktiengesellschaft: A Capital Market Information
DGAP-News: GEA Group Aktiengesellschaft: Eine Kapitalmartkinformation
Eurofins Technologies bringt den neuen Lateral-Flow-Reader RapidScan ST5-W - die einzige für mehrere Lebensmittel- und Umweltschnelltests verifizierte Plattform - auf den Markt
Eurofins Technologies (Paris:ERF), ein Anbieter von Testkits und Systemen für Laboranalysen, gibt die Markteinführung seines neuen Lateral-Flow-Readers RapidScan ST5-W bekannt, der speziell für
Eurofins Technologies launches new Lateral Flow Reader RapidScan ST5-W as a single platform validated for multiple food and environmental rapid tests
Eurofins Technologies (Paris:ERF), a supplier of test kits and systems for laboratory analyses, announces the launch of its new RapidScan ST5-W lateral flow reader, specifically designed for field
Vifor Pharma comments on media speculation
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor is in discussions with CSL about a possible transaction. No decisions have been made yet and there is no time frame for this
DGAP-News: MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis
DGAP-News: MorphoSys präsentiert neueste Daten der MANIFEST Phase 2-Studie zur Bewertung des Potenzials von Pelabresib bei der Behandlung von Myelofibrose
Xencor Presents Data from Phase 1 Study of Plamotamab in B-cell Non-Hodgkin Lymphomas at the ASH Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
DGAP-News: MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatment of r/r DLBCL
DGAP-News: MorphoSys und Incyte geben weitere 'Real World' Ergebnisse der RE-MIND2-Studie mit Tafasitamab (Monjuvi(R)) in Kombination mit Lenalidomid zur Behandlung des R/R DLBCL bekannt
DGAP-Adhoc: United Internet AG: Ralph Dommermuth prüft Angebote zu außerbörslichen Paketerwerben von Aktien an der United Internet AG
DGAP-Adhoc: United Internet AG: Ralph Dommermuth assesses offers for block acquisitions of shares in United Internet AG
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Vifor Pharma today announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult
RPM to Announce Fiscal 2022 Second-Quarter Results on January 5, 2022
RPM International Inc. (NYSE: RPM) announced today that it will release its financial results for the fiscal 2022 second quarter ended November 30, 2021, before the stock market opens on Wednesday
Guidewire Announces NXT Level Technologies as New Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that NXT Level Technologies, an insurance IT services provider specializing in Guidewire products, has joined Guidewire PartnerConnect as a Consulting alliance
Aurubis AG: Aurubis AG und Wärme Hamburg GmbH bauen größte Industriewärmeversorgung Deutschlands weiter aus
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.
Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc
Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced the appointment of Hervé Gisserot as Chief Commercial Officer and member of the Vifor Pharma
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor
DGAP-News: Stabilus S.A. bestätigt vorläufige Zahlen für GJ2021 und schlägt Dividende von 1,25 € je Aktie vor
DGAP-News: Stabilus S.A. confirms preliminary figures for FY2021 and proposes dividend of €1.25 per share
Vici Properties Inc. Declares Regular Quarterly Dividend
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.36 per share of common stock